Prevention of atherosclerosis by specific AT1-receptor blockade with candesartan cilexetil
Several studies indicate that blockade of the renin-angiotensin-aldosterone system (RAAS) can prevent atherosclerosis and vascular events, but the precise mechanisms involved are still unclear. In this study, we investigated the effect of the AT 1-receptor blocker, candesartan, in the prevention of...
Main Authors: | Vasilios Papademetriou, Philippe Mammillot, Robert Redman, Aldo Notargiacomo, Puneet Narayan, Raj Lakshman |
---|---|
Format: | Article |
Language: | English |
Published: |
Hindawi - SAGE Publishing
2001-03-01
|
Series: | Journal of the Renin-Angiotensin-Aldosterone System |
Online Access: | https://doi.org/10.1177/14703203010020011301 |
Similar Items
-
Candesartan cilexetil in cardiovascular prevention
by: A. Ya. Ivleva
Published: (2007-12-01) -
Biorelevant dissolution of candesartan cilexetil
by: Lucie Gruberová, et al.
Published: (2017-03-01) -
The Safety and Tolerability of Candesartan Cilexetil in CHF
by: Erland Erdmann, et al.
Published: (2000-03-01) -
The safety and tolerability of candesartan cilexetil in CHF
by: Erland Erdmann, et al.
Published: (2000-03-01) -
Dual blockade with candesartan cilexetil and lisinopril in hypertensive patients with diabetes mellitus: rationale and design
by: Niels H Andersen, et al.
Published: (2003-06-01)